drugset / Trial / NCT03131583
The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640, Febuxostat and Colchicine interaction in patients with gout.
Timeline
- Start
- 2017-02-17
- Primary completion
- 2018-01-29
- Completion
- 2018-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colchicine | Small molecule | 0.5 mg | Oral |
| Subject | Febuxostat | Small molecule | 80 mg | Oral |
| Subject | SHR4640 | Small molecule | 10 mg | Oral |